Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

161 Results
Title Activity Code Posting Date Sort descending Expiration Date
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement, Clinical Trial Optional)- PA-18-935 Supp October 03, 2018 January 25, 2022
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)- PA-19-020 R21 October 05, 2018 January 08, 2022
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)- PA-19-066 R21 November 13, 2018 January 08, 2022
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)- PA-19-067 R01 November 13, 2018 January 08, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-19-078 R01 November 26, 2018 January 08, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-079 R21 November 26, 2018 January 08, 2022
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)- PA-19-077 R01 November 26, 2018 January 08, 2022
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)- PA-19-080 R01 November 26, 2018 January 08, 2022
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)- PA-19-081 R21 November 26, 2018 January 08, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)- PA-19-082 R01 November 26, 2018 January 08, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)- PA-19-083 R21 November 26, 2018 January 08, 2022
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)- PA-19-096 R01 November 29, 2018 January 08, 2022
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-19-134 R15 December 21, 2018 January 08, 2022
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)- PAR-19-158 R01 January 08, 2019 January 08, 2022
Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-19-001 Multiple March 13, 2019
Novel RNAs in Virology (including HIV) and Immune Regulation—Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)- PA-19-237 R21 April 03, 2019 May 08, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-19-274 R01 May 08, 2019 May 08, 2022
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-19-275 R21 May 08, 2019 May 08, 2022
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)- PAR-19-364 R21 September 03, 2019 January 11, 2022
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)- PAR-19-357 R01 September 03, 2019 January 11, 2022
Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)- RFA-HL-20-006 K38 September 09, 2019 January 15, 2022
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-19-371 K22 September 09, 2019 January 08, 2022
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)- RFA-OD-19-029 R01 September 27, 2019 November 27, 2021
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)- PAR-20-029 R01 October 10, 2019 January 08, 2022
Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 R01 October 24, 2019 September 08, 2022